Atlas Trials

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam

Clinical trial NCT02233244 · COMPLETED

Trial details

NCT number
NCT02233244
Sponsor
Celtaxsys, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-09-01
Primary completion
2014-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.